The purpose of this research is to test a new instrument, called a fetal STAN monitor, that may be used during labor to monitor the electrical activity of the baby's heart. This new instrument is designed to help the doctor determine how well the baby is doing during labor. It will be used along with the existing electronic fetal monitor used to measure the baby's heart rate and the mother's contractions during birth. The specific purpose of this research study is to see if this new instrument (fetal STAN monitor) will have an impact on newborn health.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants With Primary Composite Outcome
Timeframe: From Delivery through 1 month of age
Number of Intrapartum Fetal Deaths (Primary Outcome Component)
Timeframe: During labor and through delivery of the baby
Number of Neonatal Deaths (Primary Outcome Component)
Timeframe: Delivery through1 month of age
Number of Infants With Apgar Score < = 3 at 5 Minutes (Primary Outcome Component)
Timeframe: 5 minutes after delivery
Number of Infants Who Experienced Neonatal Seizure (Primary Outcome Component)
Timeframe: Birth through hospital discharge
Number of Infants With Umbilical-artery Blood pH < = 7.05 and Base Deficit in Extracellular Fluid > = 12 mmol/Liter (Primary Outcome Component)
Timeframe: Delivery
Number of Neonates Intubated for Ventilation at Delivery (Primary Outcome Component)
Timeframe: Delivery
Number of Infants Experiencing Neonatal Encephalopathy (Primary Outcome Component)
Timeframe: Delivery through hospital discharge